temozolomide 180 MG Oral Capsule

Known as: TEMOZOLOMIDE 180 mg ORAL CAPSULE [Temozolomide], TEMOZOLOMIDE 180MG CAP, TEMOZOLOMIDE 180MG CAP [VA Product] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2018
02419902018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
PURPOSE Rechallenge with temozolomide (TMZ) at first progression of glioblastoma after temozolomide chemoradiotherapy (TMZ/RT→TMZ… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Cilengitide is a selective αvβ3 and αvβ5 integrin inhibitor. Data from phase 2 trials suggest that it has antitumour… (More)
Is this relevant?
2013
2013
Temozolomide, an alkylating agent against high-grade astrocytomas such as GBM (Glioblastoma Multiforme), is the leading compound… (More)
  • table 2
  • table 3
  • table 1
  • table 4
  • figure 1
Is this relevant?
2012
2012
PURPOSE Recurrent glioblastoma multiforme (GBM) is characterized by resistance to radiotherapy and chemotherapy and a poor… (More)
Is this relevant?
2010
2010
In this study, we investigated the potential of combined treatment with temozolomide (TMZ) chemotherapy and tumor antigen-pulsed… (More)
Is this relevant?
2010
2010
The primary objective of this augmental, prospective, uncontrolled phase II multicentre trial was to assess adverse events (AE… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
  • figure 3
Is this relevant?
2006
2006
Frequent regular administration of chemotherapeutic agents at low doses, known as 'metronomic chemotherapy', can increase the… (More)
  • table I
  • figure 1
  • figure 2
  • table II
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Temozolomide (8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4-(3H)-one) has shown promising activity in Phase I trials… (More)
  • figure 2
  • figure 1
  • table I
  • table II
  • figure 3
Is this relevant?
1992
1992
Temozolomide is a new anticancer agent which in the early clinical investigation has shown promising antitumor activity. It… (More)
Is this relevant?
1990
1990
The experimental antineoplastic agent temozolomide was not metabolised in vitro at a measurable rate by mouse liver fractions. In… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 8
  • figure 5
Is this relevant?